GeneDx Holdings Corp. (WGS)

Last Closing Price: 79.47 (2026-03-04)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

GeneDx Holdings Corp. (WGS) had Revenue of $120.99M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
Revenue
$120.99M
$-17.67M
$36.72M
$84.27M
$135.22M
$-14.23M
$-4.00M
$-18.23M
$-18.23M
$-17.67M
$-17.67M
$-17.67M
$-17.67M
$-14.23M
$-7.35M
28.64M
28.64M
$-0.61
$-0.59
Balance Sheet Financials
$268.29M
$45.69M
$255.42M
$523.71M
$108.91M
$48.18M
$106.62M
$215.53M
$308.18M
$126.18M
$308.18M
29.25M
Cash Flow Statement Financials
$33.28M
$-61.52M
$48.02M
$86.20M
$105.99M
$19.79M
$32.16M
--
--
Fundamental Metrics & Ratios
2.46
--
--
0.14
0.16
69.65%
-11.77%
-11.77%
--
-15.07%
-14.60%
$14.26M
--
--
--
0.23
2.63
1.63
55.32
-5.73%
-14.00%
-3.37%
-4.96%
$10.54
$0.50
$1.16